Literature DB >> 1552193

A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS.

L A Cone1, D R Woodard, R G Byrd, K Schulz, S M Kopp, P M Schlievert.   

Abstract

Although staphylococcal infections are common in patients with AIDS, staphylococcal toxin-related disorders have rarely been described. Five cases of a staphylococcal toxin-associated syndrome characterized by prolonged erythema, extensive cutaneous desquamation, hypotension, tachycardia, and multiple organ involvement are described in patients with AIDS. These illnesses were recurrent and recalcitrant with a mean duration of 50 days. Toxic shock syndrome toxin-1-producing staphylococci were isolated from three and staphylococcal enterotoxins B and A from one patient each. Sources of organisms were blood, one patient, and soft tissues and nasal accessory sinuses, two patients each. Three of the five patients died of renal failure and central nervous system abnormalities. One survivor required intubation for respiratory failure. All individuals manifested a marked diminution of CD4+ cells. Other laboratory abnormalities included azotemia and prolongation of partial thromboplastin time. Oliguria occurred in three patients. Thus, this recalcitrant erythematous desquamative disorder appears to be a variant of staphylococcal toxic shock syndrome in certain subsets of immunocompromised individuals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552193     DOI: 10.1093/infdis/165.4.638

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Lack of muco-cutaneous signs of toxic shock syndrome when T cells are absent: S. aureus shock in immunodeficient adults with multiple myeloma.

Authors:  N S Kamel; M C Banks; A Dosik; D Ursea; A A Yarilina; D N Posnett
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

4.  Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.

Authors:  J M Yarwood; P M Schlievert
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever.

Authors:  S Jarraud; G Cozon; F Vandenesch; M Bes; J Etienne; G Lina
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

Review 6.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.

Authors:  K Ami; T Ohkawa; Y Koike; K Sato; Y Habu; T Iwai; S Seki; H Hiraide
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 9.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 10.  The relationship between HIV infection and atopic dermatitis.

Authors:  Donald Rudikoff
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.